Author(s): Shaji Kumar, Simon Harrison, Michele Cavo, et. al. EHA Library. Kumar S. Jun 16, 2019; 273254; LB2601 Abstract: LB2601 Session topic: 14. Myeloma and other monoclonal gammopathies – Clinical Background Venetoclax (Ven) is a highly selective, potent, oral BCL-2 inhibitor that induces apoptosis in multiple myeloma (MM) cells and has shown...
Pro zobrazení tohoto obsahu je třeba být přihlášen.